Affinity Asset Advisors’s Vera Therapeutics VERA Stock Holding History

Affinity Asset Advisors’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.7M	Hold	250,000	–	–	0.48%	59
2026 Q1	$10.1M	Hold	250,000	–	–	0.52%	49
2025 Q4	$12.7M	Sell	250,000 -53,330	-18%	-$1.89M	0.72%	39
2025 Q3	$8.81M	Sell	303,330 -241,670	-44%	-$5.59M	0.77%	37
2025 Q2	$12.8M	Buy	545,000 +189,857	+53%	+$4.27M	1.75%	18
2025 Q1	$8.53M	Sell	355,143 -69,857	-16%	-$2.24M	0.81%	28
2024 Q4	$18M	Sell	425,000 -10,000	-2%	-$443K	2.41%	14
2024 Q3	$19.2M	Buy	435,000 +60,000	+16%	+$2.28M	2.62%	11
2024 Q2	$13.6M	Sell	375,000 -95,000	-20%	-$3.77M	1.56%	18
2024 Q1	$20.3M	Buy	+470,000	New	+$16.7M	2.51%	11

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Affinity Asset Advisors's VERA Position: Q2 2026 in Review

Affinity Asset Advisors held its Vera Therapeutics (VERA) position steady in Q2 2026 at 250,000 shares worth $10.7M. The position accounts for 0.48% of the portfolio, ranked #59.

Affinity Asset Advisors first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. The position peaked at $20.3M in Q1 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Affinity Asset Advisors held 250,000 shares of Vera Therapeutics worth $10.7M as of Q2 2026.
Affinity Asset Advisors left its Vera Therapeutics share count unchanged in Q2 2026.
Vera Therapeutics made up 0.48% of Affinity Asset Advisors's portfolio in Q2 2026, its #59 holding.
Affinity Asset Advisors first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
Affinity Asset Advisors's Vera Therapeutics position peaked at $20.3M in Q1 2024.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.